Uflex Ltd — Q1 FY27 earnings call
Summary generated by AI from the official transcript Uflex Ltd filed with BSE on 21 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
UFlex reported consolidated revenue growth of 38% year-on-year to Rs. 53,972 million in Q1 FY27, with EBITDA rising 92% to Rs. 9,198 million and EBITDA margin expanding 480 basis points to 17%. Management attributed the growth to overseas operations in Egypt, Mexico and Nigeria along with the India PET chips business, higher realizations, currency tailwinds and pass-through of raw material costs. Management said the debt-to-EBITDA ratio improved from 4.5x to 3.5x during the quarter and outlined ongoing capex projects in Egypt, Mexico, Noida and Dharwad.
Numbers mentioned
Consolidated revenue: Rs. 53,972 million (Q1 FY27)
p. 4
“Consolidated revenue for Q1 FY27 grew 38% Y-o-Y to Rs. 53,972 million.”
Arun Kumar Sharma, page 4 of the filed PDF · View the filing
EBITDA: Rs. 9,198 million (Q1 FY27)
p. 4
“EBITDA rose 92% Y-o-Y to Rs. 9,198 million with EBITDA margin expanding 480 basis points Y-o-Y to 17%, marking our highest EBITDA performance in the last 21 quarters.”
Arun Kumar Sharma, page 4 of the filed PDF · View the filing
Normalized EBITDA margin: 15.5% (Q1 FY27)
p. 4
“Normalized EBITDA post adjustment of Rs. 825 million on forex derivative transactions reached Rs. 8,373 million, which is 78% growth year-on-year, expanded to 15.5%.”
Arun Kumar Sharma, page 4 of the filed PDF · View the filing
Consolidated net profit after tax and non-controlling interest (PAT): Rs. 4,233 million (Q1 FY27)
p. 4
“Consolidated net profit after tax and non-controlling interest PAT was Rs. 4,233 million with a net margin of 7.8% compared to Rs. 580 million and a net margin of 1.5% in Q1 FY26.”
Arun Kumar Sharma, page 4 of the filed PDF · View the filing
Total sales volume: 173,471 metric tons (Q1 FY27)
p. 4
“Total sales volume for the quarter reached 173,471 metric tons, which is 1.7% year-on-year growth.”
Arun Kumar Sharma, page 4 of the filed PDF · View the filing
Packaging Films volume: 136,186 metric tons (Q1 FY27)
p. 5
“The expansion of packaging films volume to 136,186 metric tons, which is 4.9% year-on-year growth, was supported by preference of sourcing by the converters from local regional producers of film across international markets.”
Arun Kumar Sharma, page 5 of the filed PDF · View the filing
Packaging volume: 37,285 metric tons (Q1 FY27)
p. 5
“Overall Packaging volumes slipped 8.4% year-on-year to 37,285 metric tons, primarily due to strategic shift towards high-margin products in India in flexible Packaging business and softness in Aseptic Packaging due to duty-free import at aggressive prices in Indian market, while overseas volumes were impacted by larger pack sizes mix and some disruptions in consignment deliveries due to West Asia crisis.”
Arun Kumar Sharma, page 5 of the filed PDF · View the filing
Capex incurred: Rs. 4,782 million (Q1 FY27)
p. 5
“On our strategic expansion and capex front, we have incurred Rs. 4,782 million in capex in Q1, primarily allocated across 4 key projects.”
Arun Kumar Sharma, page 5 of the filed PDF · View the filing
Debt-EBITDA ratio: 3.5x (Q1 FY27)
p. 13
“Our debt was higher in FY26. Our Debt-EBITDA margin was around 4.5x, which you would see in this quarter itself, it has come down to 3.5.”
Arun Kumar Sharma, page 13 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Revenue growth — 35% growth · FY27
stated firmly by Arun Kumar Sharma
p. 8
“I think we're expecting 35% growth in our top line in this financial year.”
Arun Kumar Sharma, page 8 of the filed PDF · View the filing
EBITDA growth — same growth as revenue · FY27
stated firmly by Arun Kumar Sharma
p. 8
“And similarly, EBITDA also, we'll see the same growth coming up in this financial year as compared to last financial year.”
Arun Kumar Sharma, page 8 of the filed PDF · View the filing
Top line and bottom line growth — 30% plus · FY28 and FY29
stated as an aspiration by Arun Kumar Sharma
p. 8
“Both for top line and bottom line, you can expect a decent growth, 30% plus in coming year. And same growth will continue in FY28 also”
Arun Kumar Sharma, page 8 of the filed PDF · View the filing
Egypt Aseptic plant commissioning — commercialization · H1 FY27
stated conditionally by Arun Kumar Sharma
p. 15
“But seeing the geopolitical scenario, we are saying H1, it can be a little bit here and there, 1 or 2 weeks here and there, but we are targeting H1 as of now.”
Arun Kumar Sharma, page 15 of the filed PDF · View the filing
Debt-EBITDA leverage — 3x · FY28
stated firmly by Arun Kumar Sharma
p. 16
“Second, you asked how much debt reduction will happen. I've given you a number already. We have reduced our ratio from 4.5x to 3.5x. 1x is a big reduction, 30% reduction in our leverage. And going forward, what I'm saying is FY28, we'll be at 3x, which is further reduction.”
Arun Kumar Sharma, page 16 of the filed PDF · View the filing
Volume growth — double the volume · FY29
stated as an aspiration by Arun Kumar Sharma
p. 22
“We have right now 173,000+ tonnes. In 3 years, we should be doubling the volume because our WPP will be fully utilized by the time.”
Arun Kumar Sharma, page 22 of the filed PDF · View the filing
Interest costs — 1% · 1 year
stated as an aspiration by Arun Kumar Sharma
p. 24
“But by next 1 year, we'll reduce our interest costs by at least 1%.”
Arun Kumar Sharma, page 24 of the filed PDF · View the filing
Capex allocation to value-added products — 60% to 70% of capex
stated firmly by Arun Kumar Sharma
p. 18
“Whatever capex we do going forward, at least 60% to 70% will go into value-added products only and balance can go into maintenance or regular products”
Arun Kumar Sharma, page 18 of the filed PDF · View the filing
Egypt facility capacity utilization — 30% in first year, 60-70% second year, 100% third year · multi-year post commissioning
stated as an aspiration by Arun Kumar Sharma
p. 12
“Out of 12 billion packs, which is the annual capacity, we can do 30% in first year. Second year, certainly, we'll reach around 60% to 70%. And third year, we'll reach around 100% capacity there”
Arun Kumar Sharma, page 12 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said BOPET and BOPP prices have risen significantly since the West Asia conflict began.
Answered by Arun Kumar Sharma
Asked by Kashmira: How are price realizations shaping up in India and export markets?
p. 6
“BOPP prices have gone up by 25%, and BOPET prices have gone up by almost 30%-35% from, to be specific from February '26 level to now, it is 25-32% higher on BOPP and BOPET rate is around 30-35% higher.”
Arun Kumar Sharma, page 6 of the filed PDF · View the filing
Management said the growth reflects capex from the past 2-3 years and is sustainable, guiding 35% growth for FY27.
Answered by Arun Kumar Sharma
Asked by Randhir Kumar Singh: Is the Q1 FY27 top-line and EBITDA margin growth sustainable for the full year?
p. 8
“Just to respect as an investor, I think we're expecting 35% growth in our top line in this financial year.”
Arun Kumar Sharma, page 8 of the filed PDF · View the filing
Management clarified normalization does not mean a decline, but reflects that Q1 was exceptionally strong and guidance remains 35% growth for the year.
Answered by Arun Kumar Sharma
Asked by Saket Kapoor: What does 'normalization' mean for Q2 given Q1's strong results?
p. 9
“normalization doesn't mean that we are talking about anything or something going down. Normalization meansthat this quarter has seen tremendous growth, but what guidance we're giving is that we'll grow by 35%, which is very good growth in today's market conditions.”
Arun Kumar Sharma, page 9 of the filed PDF · View the filing
Management detailed remaining capex across Egypt, Dharwad, Mexico and Noida projects, noting most of the year's capex cycle is complete.
Answered by Arun Kumar Sharma
Asked by Saket Kapoor: Can you provide detail on the capital work in progress and remaining capex for FY27?
p. 11
“From this, you can see our capex cycle for this financial year is almost 75% done.”
Arun Kumar Sharma, page 11 of the filed PDF · View the filing
Management said prices are stable currently but tied to the ongoing West Asia crisis, and margins are expected to be maintained even if prices correct.
Answered by Arun Kumar Sharma
Asked by Rikesh Parikh: Are current elevated BOPP and PET prices stable?
p. 12
“Till this route remains high and this crisis keeps on happening in West Asia, we see the prices being in the vicinity of what they are currently.”
Arun Kumar Sharma, page 12 of the filed PDF · View the filing
Management said capex and debt should not be linked, and detailed the company's regional manufacturing strategy to be near customers.
Answered by Arun Kumar Sharma
Asked by Rikesh Parikh: Has debt peaked given the capex cycle?
p. 13
“See, first of all, let me just tell you, don't link capex and debt. Capex we're doing for growth.”
Arun Kumar Sharma, page 13 of the filed PDF · View the filing
Management said the company favors reinvestment for growth over buybacks, with surplus cash directed to debt reduction.
Answered by Arun Kumar Sharma
Asked by Chirag Singhal: How will operating cash flow be split between capex, debt reduction and shareholder returns?
p. 16
“Whatever debt reductions do happen and surplus cash we generate, they'll go for reduction of debt only and the shareholders' value will keep on increasing,”
Arun Kumar Sharma, page 16 of the filed PDF · View the filing
Management declined to give a precise figure, suggesting roughly 10% but promising to confirm with Surajit later.
Answered by Arun Kumar Sharma
Asked by Chirag Singhal: What CAGR should be expected from FY26 to FY29?
p. 17
“And I think CAGR from FY26 to FY29, 4 years, at least should be 10%. That is what I feel. But we'll reconfirm these numbers to you.”
Arun Kumar Sharma, page 17 of the filed PDF · View the filing
Management said the margins reflect capex investment and focus on value-added products and should sustain over the next several years.
Answered by Arun Kumar Sharma
Asked by Tisha Shah: Are the 15.5% normalized EBITDA margins sustainable?
p. 19
“In the beginning of the call, we said these margins are very sustainable going forward and not sustainable for this year but going forward for next 3 years.”
Arun Kumar Sharma, page 19 of the filed PDF · View the filing
Management said the company does not carry much inventory and that price gains reflect its integrated supply chain commanding premium pricing from customers.
Answered by Arun Kumar Sharma
Asked by Garvita Jain: How much of revenue growth was from cost pass-through/pricing versus structural volume or mix expansion?
p. 20
“We get the first opportunity to supply to the customers, and they are willing to pay reasonably good price to us to sustain their supply chain.”
Arun Kumar Sharma, page 20 of the filed PDF · View the filing
Management explained overseas operations command higher margins because prices can be passed through more easily to overseas customers versus India.
Answered by Arun Kumar Sharma
Asked by Kaushik Poddar: Why is domestic EBITDA/PAT contribution disproportionately low compared to the 40% domestic revenue growth?
p. 21
“Overseas business will always give a higher margin because the price at which we sell the product in overseas market is, if I can give you a ballpark figure, it's almost 2.5x of what we sell in India.”
Arun Kumar Sharma, page 21 of the filed PDF · View the filing
Management said volumes should double in 3 years as new capacities in WPP, Egypt and India recycling reach full utilization.
Answered by Arun Kumar Sharma
Asked by Kaushik Poddar: What volume growth is expected over FY27-FY29 given only 1.7% Y-o-Y volume growth this quarter?
p. 22
“Volume, yes. We have right now 173,000+ tonnes. In 3 years, we should be doubling the volume because our WPP will be fully utilized by the time.”
Arun Kumar Sharma, page 22 of the filed PDF · View the filing
Management said the company's AA- rating supports further reduction in interest costs of about 1% over the next year.
Answered by Arun Kumar Sharma
Asked by Lakshmi Narayanan: How did interest costs come down and can rates improve further?
p. 23
“I am hopeful that we should reduce our interest costs by 1% in next 1 years' time.”
Arun Kumar Sharma, page 23 of the filed PDF · View the filing
Risks flagged
Duty-free Aseptic Packaging imports from Indonesia at aggressive prices
p. 14
“What has happened in Aseptic, we are getting a lot of duty-free imports from Indonesia, where India has signed a treaty where duty-free imports keep on coming.”
Arun Kumar Sharma, page 14 of the filed PDF · View the filing
Consignment delivery disruptions due to the West Asia crisis
p. 5
“while overseas volumes were impacted by larger pack sizes mix and some disruptions in consignment deliveries due to West Asia crisis.”
Arun Kumar Sharma, page 5 of the filed PDF · View the filing
Low-priced imports pressuring European market demand
p. 5
“In Europe, sales volume was flat Y-o-Y and stood at 35,653 metric tons amid continued pressure from low-priced imports with demand expected to moderate next quarter due to seasonal holidays.”
Arun Kumar Sharma, page 5 of the filed PDF · View the filing
Geopolitical volatility affecting shipments and guidance reliability
p. 8
“Generally, we should not give guidance because guidance in today’s market scenario is very difficult. Things change very fast because of this geopolitical situation.”
Arun Kumar Sharma, page 8 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.